pISSN 1976-2283
eISSN 2005-1212

Download original image
Fig. 4. Serial changes in serum albumin (A) and cholinesterase levels (B) after the initiation of combination therapy with daclatasvir and asunaprevir in hepatitis C virus patients. p-values compared to week 0 of treatment.

FU, follow-up. *p<0.01 and p<0.0001 determined using the Kruskal-Wallis test followed by Dunn’s multiple comparison test.

Gut and Liver 2018;12:201~207 https://doi.org/10.5009/gnl17179
© Gut and Liver